| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 12/30/2010 | US20100330037 Adenoviral systems and the uses thereof |
| 12/29/2010 | WO2010150862A1 Fluorescent temperature probe and temperature measuring device using same |
| 12/29/2010 | WO2010148511A1 Chimeric influenza virus-like particles comprising hemagglutinin |
| 12/29/2010 | WO2010148496A1 Lipidated tumor- associated antigens and immunotherapeutic compositions |
| 12/29/2010 | WO2010083253A3 Cd47 related compositions and methods for treating immunological diseases and disorders |
| 12/29/2010 | WO2010068278A3 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids |
| 12/29/2010 | EP2267452A1 A soluble complex comprising a retroviral surface glycoprotein |
| 12/29/2010 | EP2267125A1 Cancer cell motility and cancer cell infiltration inhibitor |
| 12/29/2010 | EP2267026A1 Albumin fusion proteins |
| 12/29/2010 | EP2267010A2 Activatable recombinant neurotoxins |
| 12/29/2010 | EP2267009A2 Activatable recombinant neurotoxins |
| 12/29/2010 | EP2267008A2 Activatable recombinant neurotoxins |
| 12/29/2010 | EP2265646A1 Reagents and methods for detecting influenza virus proteins |
| 12/29/2010 | CN101932609A Compositions and methods to modulate cell membrane resealing |
| 12/29/2010 | CN101928718A Protein trimerization modif and application thereof |
| 12/29/2010 | CN101928348A Human TSHR extracellular fusion protein and preparation method thereof |
| 12/29/2010 | CN101928343A Monoclonal antibodies to the CLFA protein and method of use in treating or preventing infections |
| 12/29/2010 | CA2765108A1 Truncated actriib-fc fusion proteins |
| 12/28/2010 | US7858357 Immunization with bacterial ghost-based vaccines |
| 12/28/2010 | US7858356 Mutant paramyxovirus and method for production thereof |
| 12/28/2010 | US7858322 Method of determining inhibition of binding to TRPM7 protein |
| 12/28/2010 | US7858087 enhancing the complement mediated cytotoxic activity ofchimeric anti-CD20 monoclonal antibody IDEC-C2B8 (RITUXIMAB) for its target cells by contacting with the antibody; and with a donor complement protein either as fresh plasma/sera or as isolated complement components |
| 12/23/2010 | WO2010148010A1 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularih 1 (mtm1) polypeptides |
| 12/23/2010 | WO2010067339A3 Fusion protein capable of binding vegf-a and tnf-alpha |
| 12/23/2010 | US20100323956 Glucose-regulating polypeptides and methods of making and using same |
| 12/23/2010 | US20100322962 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use |
| 12/23/2010 | US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same |
| 12/23/2010 | US20100322913 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest |
| 12/22/2010 | EP2264175A1 Fibroblast growth factor homologs |
| 12/22/2010 | EP2264052A2 Activatable recombinant neurotoxins |
| 12/22/2010 | CN1836047B Methods for the production of insulin in plants |
| 12/22/2010 | CN101925612A Antibodies against cancer-associated epitope of variant nfkbib and uses thereof |
| 12/22/2010 | CN101921819A Expression and purification system using recombinant protein as label |
| 12/22/2010 | CN101921800A Escherichia coli protein expression vector using trigger factor as fusion tag and construction method and application thereof |
| 12/22/2010 | CN101921792A Method for improving antibacterial activity of antifungal protein |
| 12/22/2010 | CN101921341A Method for efficiently extracting exogenous gene expression protein of insect-resisting rice in soil |
| 12/22/2010 | CN101921340A Protein |
| 12/22/2010 | CN101921339A Soluble-expression influenza virus hemagglutinin HA2 fusion protein |
| 12/22/2010 | CN101314619B Tumour treatment vaccine CTP37CRM197 immunogen, preparation method and application thereof |
| 12/21/2010 | US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy |
| 12/21/2010 | US7855270 Genetically engineered receptor for use in the detection and analysis of protein binding activity |
| 12/21/2010 | US7855178 antagonizing the function of vascular endothelial growth factor (VEGF) receptors, platelet derived growth factor (PDGF) receptors and other receptors; for inhibition of aberrant angiogenesis and lymphangiogenesis, and inhibition of other effects of members of the PDGF/VEGF family of growth factors |
| 12/21/2010 | US7855072 System for detecting protease |
| 12/21/2010 | US7855058 Human cyclin-dependent kinase (hPNQALRE) |
| 12/21/2010 | CA2341636C Fusion proteins, dna molecules, vectors, and host cells useful for measuring protease activity |
| 12/16/2010 | WO2010144602A2 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use |
| 12/16/2010 | WO2010142035A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system |
| 12/16/2010 | US20100317540 Methods for producing members of specific binding pairs |
| 12/16/2010 | US20100316644 Truncated actriib-fc fusion proteins |
| 12/16/2010 | US20100316643 Targeted antimicrobial moieties |
| 12/16/2010 | US20100316642 Complexes of grp94 with human immunoglobulin g |
| 12/16/2010 | US20100316602 Compositions and methods for treatment of angiogenesis in pathological lesions |
| 12/16/2010 | CA2764777A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system |
| 12/15/2010 | EP2261358A2 Novel streptococcus antigen |
| 12/15/2010 | EP2261335A1 Compositions and methods for increasing bone mineralisation |
| 12/15/2010 | EP2261250A1 Albumin fusion proteins |
| 12/15/2010 | EP2261245A1 GLP-1 (glucagon-like peptide-1) fusion polypeptides with increased peptidase resistance |
| 12/15/2010 | EP2261241A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 12/15/2010 | EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof |
| 12/15/2010 | EP2259802A1 Drug fusions and conjugates |
| 12/15/2010 | EP1694709B1 Recombinant anti-cd64-eta' immunotoxins |
| 12/15/2010 | EP1353942B1 Peptide inhibitors of hiv entry |
| 12/15/2010 | EP1076703B2 Therapeutic uses of il-17 homologous polypeptides |
| 12/15/2010 | CN1802386B GLP-1 analog fusion proteins |
| 12/15/2010 | CN101918559A Modifying glycoprotein production in plants |
| 12/15/2010 | CN101918431A Cell-permeabilising peptides and polypeptides for microbial cells |
| 12/15/2010 | CN101915835A Lily mottle virus double-antibody sandwich enzyme-linked immunosorbent assay kit and preparation method |
| 12/15/2010 | CN101914565A Method for effectively expressing cationic antibacterial peptides in pichia pastoris |
| 12/15/2010 | CN101914564A Fusion of multiple enterotoxin genes of escherichia coli and application thereof |
| 12/15/2010 | CN101914563A Mycobacterium tuberculosis 38Kd-16Kd-CFP10 recombinant fusion protein and application thereof |
| 12/15/2010 | CN101914562A Mycobacterium tuberculosis 38Kd-11Kd-CFP10 recombinant fusion protein and application thereof |
| 12/15/2010 | CN101914561A Fusion protein with antibacterial and repairing function and production method and application thereof |
| 12/15/2010 | CN101914555A Novel genes encoding novel proteolytic enzymes |
| 12/15/2010 | CN101914161A Fusion protein HGF alpha-Fc for restraining tumor growth and application thereof |
| 12/15/2010 | CN101914160A Composite of hepatitis B virus core antigen and heat shock protein and preparation method and application thereof |
| 12/15/2010 | CN101003574B Recombined expression of peptide for lowering blood sugar in long acting, and application in medication for treating diabetes |
| 12/14/2010 | US7851599 Combination of an anti-ED—B fibronectin domain antibody—IL-2 fusion protein and gemcitabine |
| 12/14/2010 | US7851594 Human cytokine receptor |
| 12/14/2010 | US7851586 Peptides for activation and inhibition of δPKC |
| 12/14/2010 | US7850963 Vascular endothelial growth factor 2 |
| 12/14/2010 | CA2308116C Low-toxicity human interferon-alpha analog |
| 12/14/2010 | CA2295308C Isolated dendritic cell membrane protein genes |
| 12/14/2010 | CA2285937C Modified proteins which bind extracellular matrix components |
| 12/09/2010 | WO2010141953A2 Biomaterials, compositions, and methods |
| 12/09/2010 | WO2010141866A2 Soga polynucleotides and polypeptides and uses thereof |
| 12/09/2010 | WO2010140682A1 Gene capable of improving productivity of substance in seed, and method for utilization thereof |
| 12/09/2010 | WO2010140672A1 Gene capable of increasing protein content in seed, and method for utilization thereof |
| 12/09/2010 | WO2010090873A3 Polypeptides and their use as adjuvants |
| 12/09/2010 | US20100313283 Uses of gdnf and gdnf receptor |
| 12/09/2010 | US20100311189 Novel Receptor Nucleic Acids and Polypeptides |
| 12/09/2010 | US20100311120 Human cytokine receptor |
| 12/09/2010 | US20100310562 System for delivery into xcr1 positive cell and uses thereof |
| 12/09/2010 | CA2764589A1 Gene capable of improving material productivity in seed and method for use thereof |
| 12/09/2010 | CA2764563A1 Gene capable of increasing seed protein content and method of use thereof |
| 12/09/2010 | CA2763918A1 Soga polynucleotides and polypeptides and uses thereof |
| 12/09/2010 | CA2763626A1 Recombinant production of peptides |
| 12/09/2010 | CA2763492A1 Biomaterials, compositions, and methods |
| 12/08/2010 | EP2258849A1 Mammalian receptor proteins; related reagents and methods |
| 12/08/2010 | EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof |
| 12/08/2010 | EP2258842A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |